A bioprocessing facility showing the transfer of medicine bottles on a conveyor belt in a pharmaceutical setting.
Image: © Pongvit/Stock.adobe.com

A new bioprocessing facility in Westmeath will create 60 jobs

6 May 2021800 Views

Antylia Scientific will hire in the areas of process and medical device engineering, manufacturing, logistics and supply chain.

US-headquartered biotech company Antylia Scientific will establish a new bioprocessing facility in Co Westmeath.

The new state-of-the-art manufacturing centre will create 60 new roles in the areas of process and medical device engineering, manufacturing as well as logistics and supply chain.

Click here to check out the top sci-tech employers hiring right now.

Antylia Scientific produces peristaltic and bioprocessing solutions and has a diverse portfolio of life sciences and diagnostic products for the pharma, biopharma, healthcare and environmental markets. The company’s Masterflex business produces peristaltic pumps and pump systems.

The new bioprocessing facility in Ireland will be used to design and manufacture Masterflex’s peristaltic technologies, which are used in pharmaceutical and bioprocessing workflows for the development and production of vaccines and therapeutics.

The facility will also include a large warehouse space to store components and finished products.

This investment is expected expand access to these critical fluid path products and provide customers with shorter lead times, simplified sourcing and validation, and increased supply.

“We are thrilled to open our first facility in Ireland to produce and house Masterflex peristaltic technologies and associated fluid path products,” Brian Barnett, president of Masterflex Bioprocessing, said.

“These products are in great demand globally. The addition of this site to our Masterflex Bioprocessing family of global sites providing mission-critical products and services will help the overall biopharma industry.”

Minister for Trade Promotion, Digital and Company Regulation Robert Troy, TD, said the announcement is a strong endorsement for the midlands. “Our highly skilled workforce is just one reason why Ireland is recognised as a global hub for leading biopharmaceutical companies like Antylia Scientific,” he said.

IDA Ireland’s CEO, Martin Shanahan, added: “Antylia Scientific’s significant investment in its Mullingar facility based at the National Science Park demonstrates the company’s commitment to the midlands region.”

More information about the opportunities to join the Mullingar team can be found on Antylia Scientific’s LinkedIn page.

Jenny Darmody
By Jenny Darmody

Jenny Darmody became the deputy editor of Silicon Republic in 2020, having worked as the careers editor until June 2019. When she’s not writing about the science and tech industry, she’s writing short stories and attempting novels. She continuously buys more books than she can read in a lifetime and pretty stationery is her kryptonite. She also believes seagulls to be the root of all evil and her baking is the stuff of legends.

Loading now, one moment please! Loading